SID 0002 Myriad Genetics
- Author
- William W Baker
- Published
- Mon 02 Nov 2015
- Episode Link
- http://stocksindepth.com/myriad-genetics-strategic-outlook-discussed-in-nyc-research-analyst-day/
In Myriad's analyst day in NYC on September 14, 2015, management discussed the outlook for several new growth drivers, and it addressed challenges faced in its legacy BRCA1/2 hereditary cancer genetic testing franchise. We explore what's new, the ins and outs of each opportunity, and delve into the intricacies of companion diagnostics.
